Want to join the conversation?
$MA 2Q15 Call: Total OpEx, excluding special item up 9% or 14% on FX adjusted basis. In US, processed volume grew 7%, up 2 PPT sequentially. Processed volume outside US grew 20%, up 2 PPT from 2Q14. For FY15, on an FX adjusted basis, MA continues to expect high single digit net revenue growth and OpEx growth. FY15 total EPS dilution $0.11-0.13.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?